WM2-16067-85553
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 782 / TX
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Dose 1 — Pfizer-BioNTech
-
2021-03-12
Registered in v-safe
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling · Fatigue or tirednessAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-06
- 2021-04-07
- 2021-04-22
- 2021-04-29
-
2021-05-09
Survey response — day 35, dose 2MedDRA: Breast swelling, Breast tenderness — Feeling: FairFree text: Breast tenderness and swelling.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — day 42, dose 2MedDRA: Breast tenderness — Feeling: FairFree text: Breast tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-03
- 2021-10-04
-
2022-04-04
Survey response — 12 months, dose 2MedDRA: Dyspnoea, Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Heart palpitations and breathlessMedDRA releases: 2024-11 · check-in free text available
-
2022-04-04
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-04 | Unsuccessful |
Free text
Release 8 — day 35, dose 2
Symptoms: Breast tenderness and swelling.
Release 8 — day 42, dose 2
Symptoms: Breast tenderness
Release 11 — 12 months, dose 2
Symptoms: Heart palpitations and breathless
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast swelling | ✓ | ✓ | ✓ |
| SD | Breast tenderness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release